Alcohol and Drug. A Cochrane Handbook. losief Abraha MD. Cristina Cusi MD. Regional Health Perugia



Similar documents
Impact of Systematic Review on Health Services: The US Experience

Resources for the Prevention and Treatment of Substance Use Disorders

Treatment of opioid use disorders

One example: Chapman and Huygens, 1988, British Journal of Addiction

TREATMENTS OF SUBSTANCE USE DISORDERS THE SYSTEMATIC REVIEWS OF THE COCHRANE DRUGS AND ALCOHOL GROUP (CDAG)

The National Community Detoxification Pilot

EPIDEMIOLOGY OF OPIATE USE

MEDICAL POLICY SUBJECT: OPIOID ADDICTION TREATMENT. POLICY NUMBER: CATEGORY: Behavioral Health

Co-morbid physical disorders e.g. HIV, hepatitis C, diabetes, hypertension. Medical students will gain knowledge in

DrugFacts: Treatment Approaches for Drug Addiction

1. According to recent US national estimates, which of the following substances is associated

Advances in Addiction Science and Treatment. Mady Chalk, Ph.D., MSW Treatment Research Institute November, 2014

Treatment Approaches for Drug Addiction

13. Substance Misuse

Update and Review of Medication Assisted Treatments

Opiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio

The CCB Science 2 Service Distance Learning Program

Beyond SBIRT: Integrating Addiction Medicine into Primary Care

Medications for Alcohol and Drug Dependence Treatment

IN THE GENERAL ASSEMBLY STATE OF. Ensuring Access to Medication Assisted Treatment Act

Care Management Council submission date: August Contact Information

Opioid Agonist Therapy: The Duration Dilemma Edwin A. Salsitz, MD, FASAM Mount Sinai Beth Israel, New York, NY March 10, 2015

Research Article Predictors of Dropout from Inpatient Opioid Detoxification with Buprenorphine: A Chart Review

Buprenorphine Therapy in Addiction Treatment

Prior Authorization Guideline

Review of Drug and Alcohol Treatments in Prison and Community Settings

Psychosocial interventions in pharmacotherapy of opioid dependence: a literature review

Evidence-based best practice interventions for the treatment of drug and alcohol abuse: Annotated Information Package

CCW Task Order 16: Round 3 Clinical Condition Algorithms. Page 1 of 5 ICD-9 CODE DESCRIPTION ICD-9 CODE

Opioid/Opiate Dependent Pregnant Women

The Use of Non-Opioid Pharmacotherapies. for the Treatment of Alcohol Dependence

How To Treat Anorexic Addiction With Medication Assisted Treatment

PATHWAYS TO RECOVERY

Treatment Approaches for Drug Addiction

Using Drugs to Treat Drug Addiction How it works and why it makes sense

Non medical use of prescription medicines existing WHO advice

Contents. Acknowledgements List of abbreviations. xix xxi

Considerations in Medication Assisted Treatment of Opiate Dependence. Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT

Produced and Published by The Cabin Chiang Mai, Alcohol and Drug Rehab Centre. Copyright and How is it Treated?

Update on Buprenorphine: Induction and Ongoing Care

Use of Buprenorphine in the Treatment of Opioid Addiction

Section Editor Andrew J Saxon, MD

Substitution Therapy for Opioid Dependence The Role of Suboxone. Mandy Manak, MD, ABAM, CCSAM Methadone 101-Hospitalist Workshop, October 3, 2015

Treatment and Interventions for Opioid Addictions: Challenges From the Medical Director s Perspective

Minimum Insurance Benefits for Patients with Opioid Use Disorder The Opioid Use Disorder Epidemic: The Evidence for Opioid Treatment:

Treatment Approaches for Drug Addiction

COUNTY OF LOS ANGELES - DEPARTMENT OF MENTAL HEALTH OFFICE OF THE MEDICAL DIRECTOR. 3.4 PARAMETERS FOR THE USE OF ANXIOLYTIC MEDICATIONS October 2014

Use of Pharmacotherapies by Substance Abuse Treatment Facilities

The Federation of State Medical Boards 2013 Model Guidelines for Opioid Addiction Treatment in the Medical Office

Opioid Treatment Services, Office-Based Opioid Treatment

Patients are still addicted Buprenorphine is simply a substitute for heroin or

ANCILLARY STABILIZATION AND WITHDRAWAL. The Why And How Of Stabilizing The Patient In A Comprehensive Treatment Setting

PERSPECTIVES ON DRUGS Treatment for cocaine dependence: reviewing current evidence

Appendix to Tennessee Department of Health: Tennessee Clinical Practice Guidelines for Outpatient Management of Chronic Non- Malignant Pain

Guidelines for Cancer Pain Management in Substance Misusers Dr Jane Neerkin, Dr Chi-Chi Cheung and Dr Caroline Stirling

Applicant Webinar for BJA s Drug Court Discretionary Grant Solicitation

MEDICAL ASSISTANCE BULLETIN

ADVANCED BEHAVIORAL HEALTH, INC. Clinical Level of Care Guidelines

Prescription Drugs: Abuse and Addiction

Prescriber Behavior, Pain Treatment and Addiction Treatment

John R. Kasich, Governor Orman Hall, Director

How To Use Naltrexone Safely And Effectively

Treatments for drug misuse

Cannabis and residential treatment

Guidelines for the use of unlicensed and off label medication within NHS Fife Addiction Services

DRUG AND ALCOHOL DETOXIFICATION: A GUIDE TO OUR SERVICES

MEDICAL ASSISTANCE BULLETIN

Medical marijuana for pain and anxiety: A primer for methadone physicians. Meldon Kahan MD CPSO Methadone Prescribers Conference November 6, 2015

Triage, Assessment & Treatment Methadone 101/Hospitalist Workshop

Opioid overdose can occur when a patient misunderstands the directions

Identification, treatment and support for individuals with Alcohol & Drug Addiction in the Community

Medication-Assisted Treatment for Opiate Addiction and the Public Financing of that Treatment

Integrating Medication- Assisted Treatment (MAT) for Opioid Use Disorders into Behavioral and Physical Healthcare Settings

Drug and Alcohol Assessment

Outline. Drug and Alcohol Counseling 1 Module 1 Basics of Abuse & Addiction

Medications Used in the Treatment of Addiction Developed by Randall Webber, MPH. Alcohol Withdrawal

Putting Addiction Treatment Medications to Use: Lessons Learned

Costing report. Drug misuse: psychosocial interventions and opioid detoxification. Implementing NICE guidance. July 2007

Medication-Assisted Treatment for Opioid Addiction

Helping physicians diagnose and treat addiction to prescription drugs

MAT Counselor Education Course Exam Questions Packet Part 1

Treatment of Opioid Use Disorders in Jails and Prisons Why, When, and How

Treatment of Opioid Dependence: A Randomized Controlled Trial. Karen L. Sees, DO, Kevin L. Delucchi, PhD, Carmen Masson, PhD, Amy

Death in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery

Medication-Assisted Addiction Treatment

Developing Medications to Treat Addiction: Implications for Policy and Practice. Nora D. Volkow, M.D. Director National Institute on Drug Abuse

ONDCP. Drug Policy Information Clearinghouse FACT SHEET John P. Walters, Director

Medications for Alcohol and Opioid Use Disorders

Behavioral Health Policy: Methadone Treatment and Intensive Detoxification or Ultra-Rapid Detoxification for Opiate Addiction

Title: The Certified Medication Assisted Treatment Advocate (CMA) Training Course

Opioid dependence is a chronic relapsing condition that

SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK

National Drug Treatment Monitoring System (NDTMS) NDTMS DATA SET H

Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY

Substance Abuse During Pregnancy: Moms on Meds. Jennifer Anderson Maddron, M.D LeConte Womens Healthcare Associates

TENNESSEE BOARD OF MEDICAL EXAMINERS POLICY STATEMENT OFFICE-BASED TREATMENT OF OPIOID ADDICTION

Testimony of The New York City Department of Health and Mental Hygiene. before the

New York State Office of Alcoholism & Substance Abuse Services Addiction Services for Prevention, Treatment, Recovery

FRN Research Report January 2012: Treatment Outcomes for Opiate Addiction at La Paloma

Transcription:

Alcohol and Drug A Cochrane Handbook losief Abraha MD Regional Health Perugia of Cristina Cusi MD Outpatient Services - Neurology Clinical Institutes of Specialisation Milan Italy A John Sons, Ltd., THE COCHRANE

Contents Foreword, ix Preface, xi Acknowledgements, xii Part 1: Alcohol interventions Chapter Effectiveness of brief alcohol interventions in primary care populations, 1 Chapter 2: Brief interventions for heavy alcohol users admitted to general hospital wards, 5 Chapter 3: Alcoholics Anonymous and other for alcohol dependence, 8 Chapter 4: Mentoring adolescents to prevent substance use disorders, 10 Chapter 5: Universal prevention programmes for alcohol in young people, 12 Chapter 6: Universal prevention programmes for alcohol misuse in young people, Chapter 7: Universal prevention programmes for alcohol misuse in young people, Chapter 8: Social interventions to reduce alcohol misuse in university or College students, 19 Chapter 9: Psychosocial interventions for enrolled in alcohol treatment during 22 interventions Chapter 10: Benzodiazepines for alcohol 24 Chapter Anticonvulsants for alcohol withdrawal, 27 Chapter 12: Acamprosate for alcohol dependence, 31 Chapter 13: Baclofen for alcohol withdrawal, 34 Chapter 14: for treatment of alcohol withdrawal and prevention of relapse, 36

vi Contents Chapter 15: Psychotropic analgesic nitrous oxide for alcohol withdrawal, 40 Chapter Efficacy and safety of pharmacological interventions for the treatment of alcohol withdrawal, 43 Chapter 17: Opioid antagonists for alcohol dependence, 46 Chapter 18: interventions for pregnant enrolled in alcohol treatment, 49 Part 2: Drugs Psychosocial interventions Chapter prevention for illicit substance use disorders, 51 Chapter 20: Interventions for prevention of substance use disorders by young people delivered in settings, 54 Chapter Case management for persons with substance use disorders, 56 Chapter 22: Motivational interviewing for substance use disorders, 59 Chapter 23: Therapeutic communities for substance use disorders, 62 Chapter 24: Interventions for drug-using offenders in the courts, secure establishments and the Community, 64 Chapter 25: Psychosocial interventions for pregnant women in outpatient illicit drug treatment programmes compared to other interventions, 67 Cocaine dependence Chapter 26: Psychosocial interventions for cocaine and psychostimulant amphetamine related disorders, 69 Chapter 27: Antidepressants for cocaine dependence, 71 Chapter 28: Antipsychotic medications for cocaine dependence, 74 Chapter 29: Anticonvulsants for cocaine dependence, 76 Chapter 30: Dopamine agonists for cocaine dependence, 78 Chapter for the treatment of cocaine dependence, 82 Chapter 32: Efficacy of psychostimulant drugs for cocaine dependence, 84 Chapter 33: Auricular acupuncture for cocaine dependence, 87

Contents vii Opioid dependence Chapter 34: Psychosocial treatment for opiate dependence, 89 Chapter 35: Psychosocial and pharmacological treatments versus pharmacological treatments for Chapter 36: Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments for treatment of dependence, 94 Chapter 37: agonists for the management of withdrawal, 96 Chapter 38: Buprenorphine for the management of withdrawal, 99 Chapter 39: Buprenorphine maintenance versus placebo or methadone maintenance for dependence, 102 Chapter 40: Methadone at tapered doses for the management of withdrawal, 105 Chapter 41: Methadone maintenance at different dosages for opioid dependence, 108 Chapter 42: Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence, Chapter 43: Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal, Chapter 44: Opioid antagonists with minimal sedation for withdrawal, Chapter 45: Oral naltrexone maintenance treatment for opioid dependence, Chapter 46: Sustained-release naltrexone for opioid dependence, Chapter 47: Heroin maintenance for chronic heroin-dependent individuals, 123 Chapter 48: LAAM maintenance versus methadone maintenance for heroin dependence, 126 Chapter 49: Detoxification treatments for opiate-dependent adolescents, 129 Chapter 50: Maintenance treatments for opiate-dependent adolescents, 131 Chapter 51: Maintenance agonist treatments for opiate-dependent pregnant women, Chapter 52: Pharmacological treatment for depression during opioid agonist treatment for dependence, 135 Chapter 53: Inpatient versus other settings for detoxification for opioid dependence,

viii Contents Other drugs Chapter 54: Psychotherapeutic interventions for cannabis use or dependence in outpatient settings, 140 Chapter 55: Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings, 142 Chapter 56: Treatment for amphetamine dependence, 145 Chapter 57: Treatment for amphetamine withdrawal, 147 Chapter 58: Treatment for amphetamine psychosis, 149 Chapter 59: Treatment for dependence in adults, 151 Index, 153